Showing results (61-70 of 1,478) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|June 25, 2013
Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drugJolanta B Zawilska, Jakub WojcieszakHuman Psychopharmacology|January 3, 2013
Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled studyLadan Kashani, Firoozeh Raisi, Sepideh Saroukhani, et al.Human Psychopharmacology|December 15, 2012
Recent advances in the brain imaging of social anxiety disorderJean-Paul Fouche, Nic J A van Der Wee, Karin Roelofs, et al.Human Psychopharmacology|February 22, 2012
Effects of prolonged-release melatonin and zolpidem on postural stability in older adultsSarah Otmani, Deborah Metzger, Nathalie Guichard, et al.Human Psychopharmacology|March 28, 2013
Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosusAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Hikaru Hori, et al.Human Psychopharmacology|June 19, 2013
Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophreniaJihyung Hong, Diego Novick, Roberto Brugnoli, et al.Human Psychopharmacology|December 1, 2009
Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjectsRenan P Souza, Maria Tampakeras, Vince Basile, et al.Human Psychopharmacology|December 1, 2009
Identifying experimental methods to determine the effect of pain on attention: a review of pain, caffeine, alcohol and nicotine studiesDavid J Moore, Edmund Keogh, Christopher EcclestonHuman Psychopharmacology|December 31, 2009
Effect of metabolic blockade on the psychoactive effects of dextromethorphanLaurie A Zawertailo, Rachel F Tyndale, U Busto, et al.Human Psychopharmacology|December 31, 2009
Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safetyChris Hawley, Martin Turner, Muhammud A Latif, et al.Pageof 148